In this touchENDOCRINOLOGY interview, Dr José García-Tirado (University of Virginia, Charlottesville, VA, USA) gives an overview of RocketAP and discusses how the RocketAP compares to the USS-Virginia system and also what the next steps in the clinical development of the Rocket AP will be.
The abstract entitled: ‘RocketAP in Practice: Results from Pilot and Feasibility Trials‘ was presented at the 22nd Annual Diabetes Technology Meeting, 03-05 Nov, 2022.
Questions:
- Could you give us a brief overview of the RocketAP and its advantages over other artificial pancreas’ (APs)? (0:25)
- What have you learned through feasibility studies of the RocketAP? (4:49)
- How does the RocketAP compare to the USS-Virginia system in terms of time in range? (6:05)
- What will be the next steps in the clinical development of the Rocket AP? (8:21)
Disclosures: José García-Tirado discloses grant/research support from Dexcom.
Support: Interview supported by Touch Medical Media. Interview conducted by Shanice Allen.
Recorded as a highlight of DTM 2022
